293 related articles for article (PubMed ID: 22877927)
1. [RuII(η⁵-C₅H₅)(bipy)(PPh₃)]⁺, a promising large spectrum antitumor agent: cytotoxic activity and interaction with human serum albumin.
Tomaz AI; Jakusch T; Morais TS; Marques F; de Almeida RF; Mendes F; Enyedy EA; Santos I; Pessoa JC; Kiss T; Garcia MH
J Inorg Biochem; 2012 Dec; 117():261-9. PubMed ID: 22877927
[TBL] [Abstract][Full Text] [Related]
2. New water-soluble ruthenium(II) cytotoxic complex: biological activity and cellular distribution.
Morais TS; Santos FC; Jorge TF; Côrte-Real L; Madeira PJ; Marques F; Robalo MP; Matos A; Santos I; Garcia MH
J Inorg Biochem; 2014 Jan; 130():1-14. PubMed ID: 24145065
[TBL] [Abstract][Full Text] [Related]
3. Biological activity and cellular uptake of [Ru(η5-C5H5)(PPh3)(Me2bpy)][CF3SO3] complex.
Morais TS; Santos F; Côrte-Real L; Marques F; Robalo MP; Madeira PJ; Garcia MH
J Inorg Biochem; 2013 May; 122():8-17. PubMed ID: 23416310
[TBL] [Abstract][Full Text] [Related]
4. Screening organometallic binuclear thiosemicarbazone ruthenium complexes as potential anti-tumour agents: cytotoxic activity and human serum albumin binding mechanism.
Demoro B; de Almeida RF; Marques F; Matos CP; Otero L; Costa Pessoa J; Santos I; Rodríguez A; Moreno V; Lorenzo J; Gambino D; Tomaz AI
Dalton Trans; 2013 May; 42(19):7131-46. PubMed ID: 23519281
[TBL] [Abstract][Full Text] [Related]
5. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
Hotze AC; Bacac M; Velders AH; Jansen BA; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
J Med Chem; 2003 Apr; 46(9):1743-50. PubMed ID: 12699392
[TBL] [Abstract][Full Text] [Related]
6. Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure-Activity Relationship Study.
Yellol J; Pérez SA; Buceta A; Yellol G; Donaire A; Szumlas P; Bednarski PJ; Makhloufi G; Janiak C; Espinosa A; Ruiz J
J Med Chem; 2015 Sep; 58(18):7310-27. PubMed ID: 26313136
[TBL] [Abstract][Full Text] [Related]
7. Poly(alkylidenimine) Dendrimers Functionalized with the Organometallic Moiety [Ru(η⁵-C₅H₅)(PPh₃)₂]⁺ as Promising Drugs Against
Gouveia M; Figueira J; Jardim MG; Castro R; Tomás H; Rissanen K; Rodrigues J
Molecules; 2018 Jun; 23(6):. PubMed ID: 29914219
[TBL] [Abstract][Full Text] [Related]
8. Cellular uptake mechanisms of an antitumor ruthenium compound: the endosomal/lysosomal system as a target for anticancer metal-based drugs.
Côrte-Real L; Matos AP; Alho I; Morais TS; Tomaz AI; Garcia MH; Santos I; Bicho MP; Marques F
Microsc Microanal; 2013 Oct; 19(5):1122-30. PubMed ID: 23790186
[TBL] [Abstract][Full Text] [Related]
9. First polymer "ruthenium-cyclopentadienyl" complex as potential anticancer agent.
Valente A; Garcia MH; Marques F; Miao Y; Rousseau C; Zinck P
J Inorg Biochem; 2013 Oct; 127():79-81. PubMed ID: 23896008
[TBL] [Abstract][Full Text] [Related]
10. On the antitumor properties of novel cyclometalated benzimidazole Ru(II), Ir(III) and Rh(III) complexes.
Yellol GS; Donaire A; Yellol JG; Vasylyeva V; Janiak C; Ruiz J
Chem Commun (Camb); 2013 Dec; 49(98):11533-5. PubMed ID: 24177492
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic salan-titanium(IV) complexes: high activity toward a range of sensitive and drug-resistant cell lines, and mechanistic insights.
Manna CM; Braitbard O; Weiss E; Hochman J; Tshuva EY
ChemMedChem; 2012 Apr; 7(4):703-8. PubMed ID: 22262543
[TBL] [Abstract][Full Text] [Related]
12. Antitumor properties of five-coordinate gold(III) complexes bearing substituted polypyridyl ligands.
Sanghvi CD; Olsen PM; Elix C; Peng SB; Wang D; Chen ZG; Shin DM; Hardcastle KI; MacBeth CE; Eichler JF
J Inorg Biochem; 2013 Nov; 128():68-76. PubMed ID: 23948576
[TBL] [Abstract][Full Text] [Related]
13. Dinuclear Ru
Lenis-Rojas OA; Roma-Rodrigues C; Fernandes AR; Marques F; Pérez-Fernández D; Guerra-Varela J; Sánchez L; Vázquez-García D; López-Torres M; Fernández A; Fernández JJ
Inorg Chem; 2017 Jun; 56(12):7127-7144. PubMed ID: 28585811
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity of ruthenocene-containing β-diketones.
Kemp KC; Nell MJ; VAN Rensburg CE; Swarts JC
Anticancer Res; 2012 Jul; 32(7):2915-8. PubMed ID: 22753755
[TBL] [Abstract][Full Text] [Related]
15. Novel "ruthenium cyclopentadienyl"-peptide conjugate complexes against human FGFR(+) breast cancer.
Franco Machado J; Machuqueiro M; Marques F; Robalo MP; Piedade MFM; Garcia MH; Correia JDG; Morais TS
Dalton Trans; 2020 May; 49(18):5974-5987. PubMed ID: 32314752
[TBL] [Abstract][Full Text] [Related]
16. Multi-targeted organometallic ruthenium(II)-arene anticancer complexes bearing inhibitors of poly(ADP-ribose) polymerase-1: A strategy to improve cytotoxicity.
Wang Z; Qian H; Yiu SM; Sun J; Zhu G
J Inorg Biochem; 2014 Feb; 131():47-55. PubMed ID: 24239912
[TBL] [Abstract][Full Text] [Related]
17. Ru
Lenis-Rojas OA; Robalo MP; Tomaz AI; Carvalho A; Fernandes AR; Marques F; Folgueira M; Yáñez J; Vázquez-García D; López Torres M; Fernández A; Fernández JJ
Inorg Chem; 2018 Nov; 57(21):13150-13166. PubMed ID: 30339386
[TBL] [Abstract][Full Text] [Related]
18. Determination of in vitro absorption in Caco-2 monolayers of anticancer Ru(II)-based complexes acting as dual human topoisomerase and PARP inhibitors.
de Camargo MS; De Grandis RA; da Silva MM; da Silva PB; Santoni MM; Eismann CE; Menegário AA; Cominetti MR; Zanelli CF; Pavan FR; Batista AA
Biometals; 2019 Feb; 32(1):89-100. PubMed ID: 30506342
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative activity of dmoPTA-Ru(II) complexes against human solid tumor cells.
Ríos-Luci C; León LG; Mena-Cruz A; Pérez-Roth E; Lorenzo-Luis P; Romerosa A; Padrón JM
Bioorg Med Chem Lett; 2011 Aug; 21(15):4568-71. PubMed ID: 21719285
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of organometallic ruthenium(II) complexes with strong activity against several human cancer cell lines.
Morais TS; Silva TJ; Marques F; Robalo MP; Avecilla F; Amorim Madeira PJ; Mendes PJ; Santos I; Garcia MH
J Inorg Biochem; 2012 Sep; 114():65-74. PubMed ID: 22698866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
